IGF-1 and survival in ESRD

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 1, 2014, Pages 120-127

  Jia, Ting ^a   Axelsson, Thiane Gama ^a   Heimbürger, Olof ^a   Bárány, Peter ^a   Lindholm, Bengt ^a   Stenvinkel, Peter ^a   Qureshi, Abdul Rashid ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C RECEPTOR;

ADULT; ARTICLE; BONE METABOLISM; CHRONIC KIDNEY DISEASE; DENSITOMETRY; DUAL ENERGY X RAY ABSORPTIOMETRY; END STAGE RENAL DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MIDDLE AGED; MINERAL METABOLISM; MORTALITY; NUTRITIONAL STATUS;

ADULT; AGED; BIOLOGICAL MARKERS; BODY COMPOSITION; BONE REMODELING; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; DOWN-REGULATION; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RISK FACTORS; SWEDEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84891876021     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02470213     Document Type: Article

References (45)

1. Zapf J, Froesch ER: Insulin-like growth factors/somatomedins: Structure, secretion, biological actions and physiological role. Horm Res 24: 121-130, 1986
2. Yakar S, Rosen CJ, Beamer WG, Ackert-Bicknell CL, Wu Y, Liu JL, Ooi GT, Setser J, Frystyk J, Boisclair YR, LeRoith D: Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest 110: 771-781, 2002
3. Mak RH, Cheung WW, Roberts CT Jr.: The growth hormoneinsulin-like growth factor-I axis in chronic kidney disease. Growth Horm IGF Res 18: 17-25, 2008
4. Carrero JJ, Chmielewski M, Axelsson J, Snaedal S, Heimbürger O, Bárány P, Suliman ME, Lindholm B, Stenvinkel P, Qureshi AR: Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients. Clin Nutr 27: 557-564, 2008
5. Vasan RS, Sullivan LM, D'Agostino RB, Roubenoff R, Harris T, Sawyer DB, Levy D, Wilson PW: Seruminsulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: The Framingham Heart Study. Ann Intern Med 139: 642-648, 2003
6. Boger RH, Frystyk J, Ledet T, Moller N, Flyvbjerg A, Orskov H: Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease. Circulation 107: e193, 2003
7. Samani AA, Yakar S, LeRoith D, Brodt P: The role of the IGF system in cancer growth and metastasis: Overview and recent insights. Endocr Rev 28: 20-47, 2007
8. Wakai K, Ito Y, Suzuki K, Tamakoshi A, Seki N, Ando M, Ozasa K, Watanabe Y, Kondo T, Nishino Y, Ohno Y; JACC Study Group: Serum insulin-like growth factors, insulin-like growth factorbinding protein-3, and risk of lung cancer death: A case-control study nested in the Japan Collaborative Cohort (JACC) Study. Jpn J Cancer Res 93: 1279-1286, 2002
9. Lin Y, Tamakoshi A, Kikuchi S, Yagyu K, Obata Y, Ishibashi T, Kawamura T, Inaba Y, Kurosawa M, Motohashi Y, Ohno Y: Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death. Int J Cancer 110: 584-588, 2004
10. Harrela M, Qiao Q, Koistinen R, Tuomilehto J, Nissinen A, Seppala M, Leinonen P: High serum insulin-like growth factor binding protein-1 is associated with increased cardiovascular mortality in elderly men. Horm Metab Res 34: 144-149, 2002
11. Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D: The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: The Rancho Bernardo Study. J Clin Endocrinol Metab 89: 114-120, 2004
12. Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimbürger O, Lindholm B, Bergström J: Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am SocNephrol 13[Suppl 1]: S28-S36, 2002
13. Fernández-Reyes MJ, Alvarez-Ude F, Sánchez R, Mon C, Iglesias P, Díez JJ, Vázquez A: Inflammation and malnutrition as predictors of mortality in patients on hemodialysis. J Nephrol 15: 136-143, 2002
14. Zheng Z, Messi ML, Delbono O: Age-dependent IGF-1 regulation of gene transcription of Ca2+ channels in skeletal muscle. Mech Ageing Dev 122: 373-384, 2001
15. Scicchitano BM, Rizzuto E, Musarò A: Counteracting muscle wasting in aging and neuromuscular diseases: The critical role of IGF-1. Aging (Albany, NY Online) 1: 451-457, 2009
16. Park SH, Jia T, Qureshi AR, Barany P, Heimburger O, Larsson TE, Axelsson J, Stenvinkel P, Lindholm B: Determinants and survival implications of low bone mineral density in end-stage renal disease patients. J Nephrol 26: 485-494, 2013
17. Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T: Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55: 1899-1911, 1999
18. Guimarães SM, Lima EQ, Cipullo JP, Lobo SM, Burdmann EA: Low insulin-like growth factor-1 and hypocholesterolemia as mortality predictors in acute kidney injury in the intensive care unit. Crit Care Med 36: 3165-3170, 2008
19. Dardevet D, Sornet C, Attaix D, Baracos VE, Grizard J: Insulinlike growth factor-1 and insulin resistance in skeletal muscles of adult and old rats. Endocrinology 134: 1475-1484, 1994
20. LeRoith D, Yakar S: Mechanisms of disease: Metabolic effects of growth hormone and insulin-like growth factor 1. Nat Clin Pract Endocrinol Metab 3: 302-310, 2007
21. Fouque D, Peng SC, Shamir E, Kopple JD: Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients. Kidney Int 57: 646-654, 2000
22. Chan W, Valerie KC, Chan JC: Expression of insulin-like growth factor-1 in uremic rats: Growth hormone resistance and nutritional intake. Kidney Int 43: 790-795, 1993
23. Rosen CJ, Dimai HP, Vereault D, Donahue LR, Beamer WG, Farley J, Linkhart S, Linkhart T, Mohan S, Baylink DJ: Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities. Bone 21: 217-223, 1997
24. Bonjour JP, Ammann P, Chevalley T, Rizzoli R: Protein intake and bone growth. Can J Appl Physiol 26[Suppl]: S153-S166, 2001
25. Garnero P, Sornay-Rendu E, Delmas PD: Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women. Lancet 355: 898-899, 2000
26. Collins D, Woods A, Herd R, Blake G, Fogelman I, Wheeler M, Swaminathan R: Insulin-like growth factor-I and bone mineral density. Bone 23: 13-16, 1998
27. Kassem M, Brixen K, Blum W, Mosekilde L, Eriksen EF: No evidence for reduced spontaneous or growth-hormone-stimulated serum levels of insulin-like growth factor (IGF)-I, IGF-II or IGF binding protein 3 in women with spinal osteoporosis. Eur J Endocrinol 131: 150-155, 1994
28. Söylemezoglu O, Derici U, Arinsoy T, Hasanoglu A, Ozkaya O, Dalgic A, Bideci A, Buyan N, Hasanoglu E: Changes in bone mineral density, insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in kidney transplant recipients. A longitudinal study. Nephron 91: 468-473, 2002
29. Sugimoto T, Kanatani M, Kano J, Kobayashi T, Yamaguchi T, Fukase M, Chihara K: IGF-I mediates the stimulatory effect of high calcium concentration on osteoblastic cell proliferation. Am J Physiol 266: E709-E716, 1994
30. Schmid C, Keller C, Schläpfer I, Veldman C, Zapf J: Calcium and insulin-like growth factor I stimulation of sodium-dependent phosphate transport and proliferation of cultured rat osteoblasts. Biochem Biophys Res Commun 245: 220-225, 1998
31. Khoshniat S, Bourgine A, Julien M, Weiss P, Guicheux J, Beck L: The emergence of phosphate as a specific signaling molecule in bone and other cell types in mammals. CellMol Life Sci 68: 205-218, 2011
32. Canalis E: Insulin like growth factors and the local regulation of bone formation. Bone 14: 273-276, 1993
33. McCarthy TL, Centrella M, Canalis E: Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology 124: 1247-1253, 1989
34. Desjardins L, Liabeuf S, Renard C, Lenglet A, Lemke HD, Choukroun G, Drueke TB, Massy ZA; European Uremic Toxin (EUTox) Work Group: FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. Osteoporos Int 23: 2017-2025, 2012
35. Urena Torres P, Friedlander G, de Vernejoul MC, Silve C, Prié D: Bone mass does not correlate with the serum fibroblast growth factor 23 in hemodialysis patients. Kidney Int 73: 102-107, 2008
36. Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG: Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant 23: 586-593, 2008
37. Manghat P, Fraser WD, Wierzbicki AS, Fogelman I, Goldsmith DJ, Hampson G: Fibroblast growth factor-23 is associatedwith Creactive protein, serum phosphate and bone mineral density in chronic kidney disease. Osteoporos Int 21: 1853-1861, 2010
38. Raggi P, Bellasi A, Ferramosca E, Block GA, Muntner P: Pulse wave velocity is inversely related to vertebral bone density in hemodialysis patients. Hypertension 49: 1278-1284, 2007
39. Kanda E, Yoshida M, Sasaki S: Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients. BMC Nephrol 13: 122, 2012
40. Razzaque MS, Lanske B: Hypervitaminosis D and premature aging: Lessons learned from Fgf23 and Klotho mutant mice. Trends Mol Med 12: 298-305, 2006
41. Jacob V, LeCarpentier JE, Salzano S, Naylor V, Wild G, Brown CB, El Nahas AM: IGF-I, a marker of undernutrition in hemodialysis patients. Am J Clin Nutr 52: 39-44, 1990
42. Qureshi AR, Alvestrand A, Danielsson A, Divino-Filho JC, Gutierrez A, Lindholm B, Bergström J: Factors predicting malnutrition in hemodialysis patients: A cross-sectional study. Kidney Int 53: 773-782, 1998
43. Brüngger M, Hulter HN, Krapf R: Effect of chronic metabolic acidosis on the growth hormone/IGF-1 endocrine axis: New cause of growth hormone insensitivity in humans. Kidney Int 51: 216-221, 1997
44. Klasson-Heggebø L, Andersen LB, Wennlöf AH, Sardinha LB, Harro M, Froberg K, Anderssen SA: Graded associations between cardiorespiratory fitness, fatness, and blood pressure in children and adolescents. Br J Sports Med 40: 25-29, 2006
45. Sun G, Gagnon J, Chagnon YC, Pérusse L, Després JP, Leon AS, Wilmore JH, Skinner JS, Borecki I, Rao DC, Bouchard C: Association and linkage between an insulin-like growth factor-1 gene polymorphism and fat free mass in the HERITAGE Family Study. Int J Obes Relat Metab Disord 23: 929-935, 1999